Literature DB >> 21696392

Spermatogonial stem cells alone are not sufficient to re-initiate spermatogenesis in the rat testis following adjudin-induced infertility.

K-W Mok1, D D Mruk, W M Lee, C Y Cheng.   

Abstract

The blood-testis barrier (BTB) is a unique ultrastructure in the testis, which creates a specialized microenvironment in the seminiferous epithelium known as the apical (or adluminal) compartment for post-meiotic germ-cell development and for maintenance of an immunological barrier. In this study, we have demonstrated unequivocally that a functional and intact BTB is crucial for the initiation of spermatogenesis, in particular, the differentiation of spermatogonial stem cells (SSCs). It was shown that adult rats (∼300 g body weight, b.w.) treated with adjudin at 50 (low-dose) or 250 (high-dose) mg/kg b.w. by gavage led to germ-cell depletion from the seminiferous tubules and that >98% of the tubules were devoid of germ cells by ∼2 week and rats became infertile in both groups after the sperm reserve in the epididymis was exhausted. While the population of SSC/spermatogonia in the seminiferous tubules from both groups was similar to that of normal rats, only rats from the low-dose group were capable of re-initiating spermatogenesis; and by 20 weeks, greater than 75% of the tubules displayed normal spermatogenesis and the fertility of these rats rebounded. Detailed analysis by dual-labelled immunofluorescence analysis and a functional BTB integrity assay revealed that in both treatment groups, the BTB was disrupted from week 6 to week 12. However, the disrupted BTB 'resealed' in the low-dose group, but not in the high-dose group. Our findings illustrate that SSC/spermatogonia failed to differentiate into spermatocytes beyond A(aligned) spermatogonia in the high-dose group with a disrupted BTB. In short, these findings illustrate the critical significance of the BTB for re-initiation of spermatogenesis besides SSC and spermatogonia.
© 2011 The Authors. International Journal of Andrology © 2011 European Academy of Andrology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696392      PMCID: PMC3457811          DOI: 10.1111/j.1365-2605.2011.01183.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  50 in total

Review 1.  The spermatogonial stem cell niche.

Authors:  Dirk G de Rooij
Journal:  Microsc Res Tech       Date:  2009-08       Impact factor: 2.769

2.  The heterogeneity of spermatogonia is revealed by their topology and expression of marker proteins including the germ cell-specific proteins Nanos2 and Nanos3.

Authors:  Hitomi Suzuki; Aiko Sada; Shosei Yoshida; Yumiko Saga
Journal:  Dev Biol       Date:  2009-10-08       Impact factor: 3.582

3.  Platelet-derived growth factor receptor beta-subtype regulates proliferation and migration of gonocytes.

Authors:  Sabrina Basciani; Gabriele De Luca; Susanna Dolci; Marina Brama; Mario Arizzi; Stefania Mariani; Giuseppe Rosano; Giovanni Spera; Lucio Gnessi
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

4.  Inactivation of Nxf2 causes defects in male meiosis and age-dependent depletion of spermatogonia.

Authors:  Jieyan Pan; Sigrid Eckardt; N Adrian Leu; Mariano G Buffone; Jian Zhou; George L Gerton; K John McLaughlin; Peijing Jeremy Wang
Journal:  Dev Biol       Date:  2009-04-01       Impact factor: 3.582

5.  Varicocele-induced testicular dysfunction may be associated with disruption of blood-testis barrier.

Authors:  I T Koksal; Y Ishak; M Usta; A Danisman; E Guntekin; I C Bassorgun; A Ciftcioglu
Journal:  Arch Androl       Date:  2007 Jan-Feb

6.  Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells.

Authors:  Helen H N Yan; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  FASEB J       Date:  2008-01-11       Impact factor: 5.191

7.  Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.

Authors:  Christina Tenenhaus Dann; Alma L Alvarado; Laura A Molyneux; Bray S Denard; David L Garbers; Matthew H Porteus
Journal:  Stem Cells       Date:  2008-08-21       Impact factor: 6.277

8.  Claudin-11 is over-expressed and dislocated from the blood-testis barrier in Sertoli cells associated with testicular intraepithelial neoplasia in men.

Authors:  Cornelia Fink; Roswitha Weigel; Ludger Fink; Jochen Wilhelm; Sabine Kliesch; Martina Zeiler; Martin Bergmann; Ralph Brehm
Journal:  Histochem Cell Biol       Date:  2009-02-25       Impact factor: 4.304

9.  Expression of the pluripotency marker UTF1 is restricted to a subpopulation of early A spermatogonia in rat testis.

Authors:  Maaike P A van Bragt; Hermien L Roepers-Gajadien; Cindy M Korver; Jan Bogerd; Akihiko Okuda; Bart J L Eggen; Dirk G de Rooij; Ans M M van Pelt
Journal:  Reproduction       Date:  2008-04-04       Impact factor: 3.906

10.  UTF1 is a chromatin-associated protein involved in ES cell differentiation.

Authors:  Vincent van den Boom; Susanne M Kooistra; Marije Boesjes; Bart Geverts; Adriaan B Houtsmuller; Koshiro Monzen; Issei Komuro; Jeroen Essers; Loes J Drenth-Diephuis; Bart J L Eggen
Journal:  J Cell Biol       Date:  2007-09-04       Impact factor: 10.539

View more
  47 in total

1.  Testin and actin are key molecular targets of adjudin, an anti-spermatogenic agent, in the testis.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-04

2.  Fibroblast growth factor receptor 3 is highly expressed in rarely dividing human type A spermatogonia.

Authors:  Kathrein von Kopylow; Hannah Staege; Wolfgang Schulze; Hans Will; Christiane Kirchhoff
Journal:  Histochem Cell Biol       Date:  2012-07-10       Impact factor: 4.304

Review 3.  Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) - Lesson from Adjudin.

Authors:  Haiqi Chen; Dolores D Mruk; Weiliang Xia; Michele Bonanomi; Bruno Silvestrini; Chuen-Yan Cheng
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

4.  AKAP9, a Regulator of Microtubule Dynamics, Contributes to Blood-Testis Barrier Function.

Authors:  Deepak Venkatesh; Dolores Mruk; Jan M Herter; Xavier Cullere; Katarzyna Chojnacka; C Yan Cheng; Tanya N Mayadas
Journal:  Am J Pathol       Date:  2015-12-10       Impact factor: 4.307

5.  Interactions of laminin β3 fragment with β1-integrin receptor: A revisit of the apical ectoplasmic specialization-blood-testis-barrier-hemidesmosome functional axis in the testis.

Authors:  C Yan Cheng; Pearl Py Lie; Ka-Wai Mok; Yan-Ho Cheng; Elissa Wp Wong; Jayakanthan Mannu; Premendu P Mathur; Helen H N Yan; Dolores D Mruk
Journal:  Spermatogenesis       Date:  2011-07-01

6.  A study to assess the assembly of a functional blood-testis barrier in developing rat testes.

Authors:  Ka-Wai Mok; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011-07-01

7.  Actin-binding protein drebrin E is involved in junction dynamics during spermatogenesis.

Authors:  Michelle Wm Li; Xiang Xiao; Dolores D Mruk; Yee-Ling Lam; Will M Lee; Wing-Yee Lui; Michele Bonanomi; Bruno Silvestrini; C Yan Cheng
Journal:  Spermatogenesis       Date:  2011 Apr-Jun

8.  Regulation of blood-testis barrier dynamics by desmosome, gap junction, hemidesmosome and polarity proteins: An unexpected turn of events.

Authors:  C Yan Cheng; Elissa Wp Wong; Pearl Py Lie; Michelle Wm Li; Dolores D Mruk; Helen Hn Yan; Ka-Wai Mok; Jayakanthan Mannu; Premendu P Mathur; Wing-Yee Lui; Will M Lee; Michele Bonanomi; Bruno Silvestrini
Journal:  Spermatogenesis       Date:  2011-04

9.  Filamin A is a regulator of blood-testis barrier assembly during postnatal development in the rat testis.

Authors:  Wenhui Su; Dolores D Mruk; Pearl P Y Lie; Wing-Yee Lui; C Yan Cheng
Journal:  Endocrinology       Date:  2012-08-07       Impact factor: 4.736

Review 10.  Mammalian target of rapamycin complex (mTOR) pathway modulates blood-testis barrier (BTB) function through F-actin organization and gap junction.

Authors:  Nan Li; C Yan Cheng
Journal:  Histol Histopathol       Date:  2016-03-09       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.